United Arab Emirates · Delayed Price · Currency is AED Pure Health Holding PJSC Statistics
Total Valuation
ADX:PUREHEALTH has a market cap or net worth of AED 27.22 billion. The enterprise value is 41.12 billion.
| Market Cap | 27.22B |
| Enterprise Value | 41.12B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Apr 10, 2026 |
Share Statistics
ADX:PUREHEALTH has 11.11 billion shares outstanding.
| Current Share Class | 11.11B |
| Shares Outstanding | 11.11B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.23% |
| Owned by Institutions (%) | 0.17% |
| Float | 2.48B |
Valuation Ratios
The trailing PE ratio is 12.26 and the forward PE ratio is 10.86. ADX:PUREHEALTH's PEG ratio is 0.83.
| PE Ratio | 12.26 |
| Forward PE | 10.86 |
| PS Ratio | 0.92 |
| PB Ratio | 1.41 |
| P/TBV Ratio | 3.86 |
| P/FCF Ratio | 9.08 |
| P/OCF Ratio | 6.92 |
| PEG Ratio | 0.83 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.33, with an EV/FCF ratio of 13.72.
| EV / Earnings | 18.52 |
| EV / Sales | 1.39 |
| EV / EBITDA | 9.33 |
| EV / EBIT | 13.52 |
| EV / FCF | 13.72 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.94.
| Current Ratio | 1.23 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 4.11 |
| Debt / FCF | 6.04 |
| Interest Coverage | 3.11 |
Financial Efficiency
Return on equity (ROE) is 11.14% and return on invested capital (ROIC) is 8.01%.
| Return on Equity (ROE) | 11.14% |
| Return on Assets (ROA) | 3.56% |
| Return on Invested Capital (ROIC) | 8.01% |
| Return on Capital Employed (ROCE) | 7.36% |
| Weighted Average Cost of Capital (WACC) | 6.86% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.55 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ADX:PUREHEALTH has paid 253.01 million in taxes.
| Income Tax | 253.01M |
| Effective Tax Rate | 10.15% |
Stock Price Statistics
The stock price has decreased by -12.81% in the last 52 weeks. The beta is 0.72, so ADX:PUREHEALTH's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -12.81% |
| 50-Day Moving Average | 2.66 |
| 200-Day Moving Average | 2.41 |
| Relative Strength Index (RSI) | 32.05 |
| Average Volume (20 Days) | 1,765,779 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ADX:PUREHEALTH had revenue of AED 29.63 billion and earned 2.22 billion in profits. Earnings per share was 0.20.
| Revenue | 29.63B |
| Gross Profit | 7.24B |
| Operating Income | 3.04B |
| Pretax Income | 2.49B |
| Net Income | 2.22B |
| EBITDA | 4.07B |
| EBIT | 3.04B |
| Earnings Per Share (EPS) | 0.20 |
Balance Sheet
The company has 4.21 billion in cash and 18.11 billion in debt, with a net cash position of -13.90 billion or -1.25 per share.
| Cash & Cash Equivalents | 4.21B |
| Total Debt | 18.11B |
| Net Cash | -13.90B |
| Net Cash Per Share | -1.25 |
| Equity (Book Value) | 19.32B |
| Book Value Per Share | 1.74 |
| Working Capital | 3.64B |
Cash Flow
In the last 12 months, operating cash flow was 3.94 billion and capital expenditures -938.88 million, giving a free cash flow of 3.00 billion.
| Operating Cash Flow | 3.94B |
| Capital Expenditures | -938.88M |
| Depreciation & Amortization | 1.02B |
| Net Borrowing | -2.66B |
| Free Cash Flow | 3.00B |
| FCF Per Share | 0.27 |
Margins
Gross margin is 24.44%, with operating and profit margins of 10.26% and 7.50%.
| Gross Margin | 24.44% |
| Operating Margin | 10.26% |
| Pretax Margin | 8.41% |
| Profit Margin | 7.50% |
| EBITDA Margin | 13.72% |
| EBIT Margin | 10.26% |
| FCF Margin | 10.11% |
Dividends & Yields
This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 2.21%.
| Dividend Per Share | 0.05 |
| Dividend Yield | 2.21% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 15.78% |
| FCF Payout Ratio | 21.64% |
| Buyback Yield | n/a |
| Shareholder Yield | 2.21% |
| Earnings Yield | 8.16% |
| FCF Yield | 11.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for ADX:PUREHEALTH is 3.75, which is 53.22% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 3.75 |
| Price Target Difference | 53.22% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 8.95% |
| EPS Growth Forecast (3Y) | 14.81% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |